News

BioNeutra Lists on The TSX Venture Exchange

EDMONTON, Alberta, December 8, 2015 – BioNeutra Global Corporation (CSE: BGA) (“BioNeutra” or the “Company“) is pleased to announce that the common shares of the Company will be listed on the TSX Venture Exchange (the “Exchange”) under the trading symbol “BGA” on December 9, 2015, as set out in the Exchange bulletin dated December 8, 2015.

Capitalization: 45,819,787 common shares
Escrowed Shares: 18,216,718 common shares
Transfer Agent: Computershare Trust Company of Company
Trading Symbol: BGA
CUSIP Number: 09073L 10 6

An application with respect to the voluntary delisting of common shares of BioNeutra was filed with the Canadian Securities Exchange and as a result BioNeutra will no longer be listed on the Canadian Securities Exchange effective prior to the market open on Wednesday, December 9, 2015.

About BioNeutra Global Corporation
BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides.

The Company’s lead product, VitaFiber™, is an advanced functional and health food ingredient scientifically made from natural agricultural products, is generally regarded as safe (GRAS) by the U.S. Food & Drug Administration, and is European Food Safety Authority and Health Canada approved. VitaFiber™ is naturally sweet and lower in calories than regular sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health.

The Company produces VitaFiber™ using its patented processes that naturally transforms starch molecules from agriculture cereal crops including corn, wheat, barley, potato, or tapioca into the functional health molecules of isomalto-oligosaccharide (IMO). The VitaFiber™ manufacturing process is based upon a natural enzymatic conversion of starch molecules without any chemical modification involved, making VitaFiber™ a natural food ingredient. VitaFiber™ is also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic.

The Company’s customers include a mix of small and medium enterprises and a number of high-profile food manufacturers in Canada, the U.S., Europe, the United Kingdom, and Mexico. VitaFiber™ is also available for retail purchase across the globe through Amazon.com and other direct-to-consumer retailers.

Further information about BioNeutra is available on the Company’s website at www.bioneutra.ca, the SEDAR website at www.sedar.com and on the CSE website at www.thecse.ca.

For further information contact:

BioNeutra Global Corporation
Bill Smith, Chairman & Senior Vice President
T: (780) 466-1481 x 117
E: bsmith@bioneutra.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of BioNeutra. Forward-looking information is based on certain key expectations and assumptions made by the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.

share thisEmail this to someoneShare on FacebookTweet about this on TwitterShare on LinkedIn

BioNeutra

9608 25 Avenue NW
Edmonton, Alberta T6N 1J4
Canada
Tel: 1.780.466.1481
Fax: 1.780.801.0036

©2017 BioNeutra